Randomized, open-label, comparative study to evaluate early viral load reductions and exploratory viral kinetics following administration of entecavir or adefovir in nucleoside-naive adults with chronic hepatitis B infection.
Phase of Trial: Phase III
Latest Information Update: 04 Aug 2010
At a glance
- Drugs Entecavir (Primary) ; Adefovir dipivoxil
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms EARLY
- Sponsors Bristol-Myers Squibb
- 23 Apr 2008 Status changed from in progress to completed; results at 96 weeks reported at EASL 2008.
- 22 Oct 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History